ProCE Banner Activity


Expert Analysis and Conference Coverage of ADA 2023

Conference Coverage

This CME-accredited video module provides cardiovascular highlights of ADA 2023 with key takeaways, including considerations for primary prevention patients, new medications for weight loss, and novel implementation science. 

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Released: July 03, 2023

Expiration: July 02, 2024



Payal Kohli

Payal Kohli, MD, FACC

Assistant Clinical Professor of Medicine
Department of Medicine
University of Colorado Anschutz
Founder and Medical Director
Department of Cardiology
Cherry Creek Heart
Aurora, Colorado

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


This program is supported by an educational grant from Esperion Therapeutics.

Esperion Therapeutics

Target Audience

This program is intended for physicians—including residents and fellows—practicing in cardiology, endocrinology, and primary care who manage patients with dyslipidemia.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Dyslipidemia.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify key data presented at ADA 2023 on dyslipidemia

  • Translate key data on dyslipidemia presented at ADA 2023 to patient care


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Payal Kohli, MD, FACC

Assistant Clinical Professor of Medicine
Department of Medicine
University of Colorado Anschutz
Founder and Medical Director
Department of Cardiology
Cherry Creek Heart
Aurora, Colorado

Payal Kohli, MD, FACC: consultant/advisor/speaker: Amarin, Amgen, AstraZeneca, Boston Scientific, Esperion, Merck, Novartis, Zoll.

The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 0.25 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from July 03, 2023, through July 02, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


Joint Accreditation Statement

Joint AccreditationIn support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.